Alternate Ocean Investment Company

Alternate Ocean Investment Company is a Hong Kong-based investment entity and a wholly owned subsidiary of Haitong International Securities Group Limited. Publicly available references to the company primarily appear in the context of a 2021 unsolicited, non-binding proposal to acquire Global Cord Blood Corporation, a cord blood banking company. The available evidence indicates that Alternate Ocean acts on behalf of funds and entities it manages or advises rather than operating as a drug developer, healthcare services company, or life sciences platform. There is no evidence that it has a therapeutic pipeline, R&D programs, or commercial healthcare products or services of its own. For biotech and healthcare diligence purposes, it should be classified as a financial/investment vehicle rather than a life sciences operating company.